Skip to content
clinical trials
-
FDA issues draft guidance to reduce primate testing in monoclonal antibody development
Macaque monkeys serve as the most common species for drug testing because they share considerable physiological similarities with humans.
-
Genmab halts phase 1/2 trial for oncology candidate GEN1160 amid broader strategic review
GEN1160 now joins GEN1107 on Genmab’s list of discontinued assets from the April 2024 ProfoundBio acquisition.